Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aims of this study are to compare the effectiveness of antifungal foam versus antifungal shampoo and determine patient compliance and satisfaction with both vehicles among African American females with dandruff practicing less than once weekly hair washing.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: St. Louis University
• Treatments: Ketoconazole

Criteria

Inclusion Criteria:

• African American females aged 18 to 89 years

• Previous diagnosis of seborrheic dermatitis of the scalp

• TDSS between 50 and 200

• Practice less than or equal to once weekly hair washing

• Immunocompetent

• Willing to not grease or oil scalp

Exclusion Criteria:

• Age below 18 years or above 89 years

• Medical history of psoriasis, diabetes mellitus, immunosuppression, neurologic disorders, and/or chronic disease not stabilized by medication

• Patients taking any oral steroids and/or antifungals within 30 days of enrollment

• Sensitivity to any formulation components of either ketoconazole foam or shampoo including sulfur

• The use of any topical medications including over the counter products indicated for the treatment of seborrheic dermatitis within 14 days of enrollment

• Pregnant women, women who plan on becoming pregnant, or breastfeeding women

• Current use or history of using any biologic medication